专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

71. 发明申请

WO2009105938A1 ORIENTED FILMS COMPRISING ETHYLENE/Α-OLEFIN BLOCK INTERPOLYMER 审中-公开
标题翻译：包含乙烯/α-烯烃嵌段共聚物的定向膜
公开(公告)号：WO2009105938A1
公开(公告)日：2009-09-03
申请号：PCT/CN2008/070390
申请日：2008-02-29
申请人： DOW GLOBAL TECHNOLOGIES INC. , YUN, Xiaobing , LAI, Shih-Yaw , LI, Jing , CHEN, HongYu , MAEHARA, Yutaka
发明人： YUN, Xiaobing , LAI, Shih-Yaw , LI, Jing , CHEN, HongYu , MAEHARA, Yutaka
IPC分类号： C08L23/04 , C08J5/18
CPC分类号： C08J5/18 , C08J2323/08 , C08L23/04 , C08L23/0815 , Y10T428/2495 , Y10T428/31909 , C08L2666/04
摘要： The present invention relates to oriented films having improved shrinkage force, shrinkage temperature, tear strength, seal strength and/or bubble stability. For example, the shrink tension of the oriented film stretched at 110 0 C is less than 3 MPa. The oriented film comprises a polymer composition comprising at least one ethylene/α- olefin interpolymer, wherein the ethylene/α-olefm interpolymer may have, for example, a M w /M n from about 1.7 to about 3.5, at least one melting point, T m , in degrees Celsius, and a density, d, in grams/cubic centimeter, wherein the numerical values of Tm and d correspond to the relationship: Tm > -6553.3 + 13735(d) - 7051.7(d) 2 .
摘要翻译：本发明涉及具有改进的收缩力，收缩温度，撕裂强度，密封强度和/或气泡稳定性的取向膜。例如，在1100℃拉伸的取向膜的收缩张力小于3MPa。取向膜包括含有至少一种乙烯/α-烯烃互聚物的聚合物组合物，其中乙烯/α-烯烃互聚物可以具有例如约1.7至约3.5的Mw / Mn，至少一个熔点Tm ，以克/立方厘米为单位的密度d，其中Tm和d的数值对应于Tm> -6553.3 + 13735（d）-7051.7（d）2的关系。

72. 发明申请

WO2007098170A1 ANTIBODIES AGAINST HUMAN IL-22 AND USES THEREFOR 审中-公开
标题翻译：抗人IL-22的抗体及其用途
公开(公告)号：WO2007098170A1
公开(公告)日：2007-08-30
申请号：PCT/US2007/004430
申请日：2007-02-21
申请人： WYETH , CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED , LI, Jing , GILL, Davinder, S. , VELDMAN, Geertruida, M. , FOUSER, Lynette, A. , VALGE-ARCHER, Viia , LOWE, David, C. , RUSSELL, Caroline, S. , COHEN, Suzanne, E. , THOM, Albert, B. , MINTER, Ralph, R.
发明人： LI, Jing , GILL, Davinder, S. , VELDMAN, Geertruida, M. , FOUSER, Lynette, A. , VALGE-ARCHER, Viia , LOWE, David, C. , RUSSELL, Caroline, S. , COHEN, Suzanne, E. , THOM, Albert, B. , MINTER, Ralph, R.
IPC分类号： C07K16/24 , C07K14/54
CPC分类号： C07K16/244 , C07K2317/21 , C07K2317/33 , C07K2317/622 , C07K2317/73 , C07K2317/76 , C07K2317/92
摘要： The present application provides human antibodies and antigen binding fragments thereof that specifically bind to the human interleukin-22 (IL-22). The antibodies can act as antagonists of IL-22 activity, thereby modulating immune responses in general, and those mediated by IL-22 in particular. The disclosed compositions and methods may be used for example, in diagnosing, treating or preventing inflammatory disorders, autoimmune diseases, allergies, septic shock, infectious disorders, transplant rejection, cancer, and other immune system disorders.
摘要翻译：本申请提供特异性结合人白细胞介素-22（IL-22）的人抗体及其抗原结合片段。抗体可以作为IL-22活性的拮抗剂，从而调节一般的免疫应答，特别是由IL-22介导的那些。所公开的组合物和方法可用于例如诊断，治疗或预防炎性疾病，自身免疫性疾病，过敏，败血性休克，感染性疾病，移植排斥，癌症和其他免疫系统疾病。

73. 发明申请

WO2004045759A2 POROUS POLYMERIC COORDINATION COMPOUNDS 审中-公开
标题翻译：多孔聚合物协同化合物
公开(公告)号：WO2004045759A2
公开(公告)日：2004-06-03
申请号：PCT/US2003/037269
申请日：2003-11-20
申请人： RUTGERS, THE STATE UNIVERSITY , LI, Jing , PAN, Long , HUANG, Xiaoying
发明人： LI, Jing , PAN, Long , HUANG, Xiaoying
IPC分类号： B01J
CPC分类号： C07F15/065
摘要： The present invention describes three-dimensional porous coordination compounds, a method of making the compounds, and a method of using the compounds to contain reactants in a reaction, said compounds characterized by a plurality of sheets comprising a two-dimensional array of repeating structural units comprising at least one transition metal, one polyfunctional ligand and one exodentate ligand wherein: (1) at least one binding member of each said polyfunctional ligand is coordinated to transition metal atoms in two different repeating structural units within one sheet; (2) said binding sites of each exodentate bridging ligand are coordinated to transition metal atoms in a each of two adjacent sheets, and (3) the ligands of the three-dimensional polymeric compound define channels and pores of molecular size throughout the structure of the compound.
摘要翻译：本发明描述了三维多孔配位化合物，一种制备该化合物的方法，以及一种在反应中使用该化合物含有反应物的方法，所述化合物的特征在于包括重复结构单元的二维阵列包括至少一种过渡金属，一种多官能配体和一种外分子配体，其中：（1）每个所述多官能配体的至少一个结合成员与一片中两个不同重复结构单元中的过渡金属原子配位; （2）每个外部桥接配体的所述结合位点与两个相邻片段中的每一个中的过渡金属原子配位，并且（3）三维聚合物的配体在整个结构中定义分子大小的通道和孔复合。

74. 发明申请

WO2003100000A2 AMPLIFICATION AND OVEREXPRESSION OF ONCOGENES 审中-公开
标题翻译：放大和过度表达
公开(公告)号：WO2003100000A2
公开(公告)日：2003-12-04
申请号：PCT/US2003/016049
申请日：2003-05-22
申请人： TULARIK INC. , LI, Jing , MU, David , YANG, Jianxin
发明人： LI, Jing , MU, David , YANG, Jianxin
IPC分类号： C12N
CPC分类号： C12N15/1135 , C07K14/4702 , C12Q1/6886 , C12Q2600/136
摘要： There are disclosed methods and compositions for the diagnosis, prevention, and treatment of tumors and cancers in mammals, for example, humans, utilizing the RecQL5, CTXL, USP13, MCL1, and Pellino1 genes, which are amplified in many types of cancer. The RecQL5, CTXL, USP13, MCL1, and Pellino1 genes, their expressed protein products and antibodies are used diagnostically or as targets for cancer therapy or as vaccines; they also are used to identify compounds and reagents useful in cancer diagnosis, prevention, and therapy.
摘要翻译：公开了利用在许多类型的癌症中扩增的RecQL5，CTXL，USP13，MCL1和Pellino1基因来诊断，预防和治疗哺乳动物（例如人）中的肿瘤和癌症的方法和组合物。 RecQL5，CTXL，USP13，MCL1和Pellino1基因，其表达的蛋白质产物和抗体用于诊断或作为癌症治疗或疫苗的靶标; 它们也用于鉴定可用于癌症诊断，预防和治疗的化合物和试剂。

75. 发明申请

WO2003018769A3 AMPLIFIED GENE INVOLVED IN CANCER 审中-公开
公开(公告)号：WO2003018769A3
公开(公告)日：2003-03-06
申请号：PCT/US2002/027187
申请日：2002-08-27
申请人： TULARIK INC. , LI, Jing
发明人： LI, Jing
IPC分类号： C12Q1/68
摘要： There are disclosed methods and compositions for the diagnosis, prevention, and treatment of tumors and cancers in mammals, for example, humans, utilizing the C8FW gene, which are amplified breast and/or brain and/or colon and/or lung and/or prostate and/or ovarian cancer genes. The C8FW gene, its expressed protein products and antibodies are used diagnostically or as targets for cancer therapy or vaccine; they are also used to identify compounds and reagents useful in cancer diagnosis, prevention, and therapy.

76. 发明申请

WO2022126306A1 TECHNIQUES FOR TRANSMISSION CONFIGURATION INDICATOR STATE SWITCHING FOR HANDOVER PROCEDURES 审中-公开
公开(公告)号：WO2022126306A1
公开(公告)日：2022-06-23
申请号：PCT/CN2020/136039
申请日：2020-12-14
申请人： QUALCOMM INCORPORATED , VAZE, Chinmay Shankar , HSU, Chun-Hao , YENIGALLA, Priyanka , KARAKKAD KESAVAN NAMBOODIRI, Vishnu Namboodiri , LIU, Zhanyi , LI, Jing , MOHANTY, Rashmi Ranjan
发明人： VAZE, Chinmay Shankar , HSU, Chun-Hao , YENIGALLA, Priyanka , KARAKKAD KESAVAN NAMBOODIRI, Vishnu Namboodiri , LIU, Zhanyi , LI, Jing , MOHANTY, Rashmi Ranjan
IPC分类号： H04W36/00
摘要： Methods, systems, and devices for wireless communications are described. Generally, a user equipment (UE) may communicate with a first network device in a first communications system (e.g., a non-standalone (NSA) system) prior to initiating a handover to a second communications system (e.g., a standalone (SA) system). In some examples, the UE may receive a first tracking reference signal (TRS) from the first network device using a first transmission configuration indicator (TCI) state. The first network device may include an indication of the first TCI state in a control message. The UE may initiate a handover from the first network device to the second network device. Subsequent to the handover, the UE may receive a second TRS from the second network device. The UE may receive the second TRS using the first TCI state based on determining that one or more antenna port configuration conditions are satisfied.

77. 发明申请

WO2021000925A1 PYRROLO [2, 3-b] PYRAZINES AS HPK1 INHIBITOR AND THE USE THEREOF 审中-公开
公开(公告)号：WO2021000925A1
公开(公告)日：2021-01-07
申请号：PCT/CN2020/100037
申请日：2020-07-03
申请人： BEIGENE, LTD. , LI, Jing
发明人： LI, Jing , WANG, Zhiwei , XU, Sanjia
IPC分类号： C07D471/00 , C07D487/00 , C07D487/04 , C07D487/02 , A61K31/517 , A61K31/519 , A61K31/437 , A61P35/00
摘要： Disclosed herein is a compound of Formula (I), or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, and pharmaceutical compositions comprising thereof. Also disclosed is a method of treating HPK1 related disorders or diseases by using the compound disclosed herein.

78. 发明申请

WO2015074245A1 ADAPTIVE TIMER FOR OPTIMIZED INTER RADIO ACCESS TECHNOLOGY SWITCHING DELAY IN DUAL RADIO DEVICE 审中-公开
标题翻译：自适应定时器用于优化的无线电接入技术在双无线电设备中的切换延迟
公开(公告)号：WO2015074245A1
公开(公告)日：2015-05-28
申请号：PCT/CN2013/087686
申请日：2013-11-22
申请人： QUALCOMM INCORPORATED , NAN, Mingkai , WANG, Huan , LI, Jing
发明人： NAN, Mingkai , WANG, Huan , LI, Jing
IPC分类号： H04W48/16
CPC分类号： H04W48/18
摘要： Methods, systems, and devices are described for switching communications between networks that utilize different RATs. A UE may determine that a condition has been met relating to the availability of a first network. The condition may relate to receiving an Out of Service (OOS) or Radio Link Failure (RLF) indication, or it may relate to an indication that a new network has been detected that may be available to provide service. The UE may then adaptively select a timing period according to a RAT switching scheme based at least in part on the condition. The UE may then initiate a timer based on the timing period. The timer may be used to determine when to terminate a search attempt or an attempt to establish an interface with the a new network.
摘要翻译：描述了用于切换利用不同RAT的网络之间的通信的方法，系统和设备。 UE可以确定已经满足与第一网络的可用性有关的条件。该条件可以涉及接收停止服务（OOS）或无线电链路故障（RLF）指示，或者它可以涉及已经检测到可能可用于提供服务的新网络的指示。然后，UE可以至少部分地基于条件自适应地选择根据RAT切换方案的定时周期。然后，UE可以基于定时周期启动定时器。定时器可用于确定何时终止搜索尝试或尝试与新网络建立接口。

79. 发明申请

WO2012167033A2 METHOD AND SYSTEM FOR DISPLAYING RELATED PRODUCT INFORMATION 审中-公开
标题翻译：用于显示相关产品信息的方法和系统
公开(公告)号：WO2012167033A2
公开(公告)日：2012-12-06
申请号：PCT/US2012/040399
申请日：2012-06-01
申请人： ALIBABA GROUP HOLDING LIMITED , LI, Jing , GONG, Yitao , MCNUTT, Gregory , YE, Jun
发明人： LI, Jing , GONG, Yitao , MCNUTT, Gregory , YE, Jun
IPC分类号： G06Q30/02
CPC分类号： G06Q30/0631 , G06Q30/02
摘要： Displaying related product information includes receiving a request to display main product information of a requested main product, retrieving related product information for a plurality of related products of the requested main product from a product relationship center, selecting a predetermined number of related products based at least in part on association strengths between the requested main product and a plurality of related products of the requested main product, and displaying product information of the selected related products.
摘要翻译：显示相关产品信息包括接收请求以显示所请求的主要产品的主要产品信息，从产品关系中心检索所请求的主要产品的多个相关产品的相关产品信息，至少选择预定数量的相关产品部分地是所请求的主要产品和所请求的主要产品的多个相关产品之间的关联强度，并且显示所选择的相关产品的产品信息。

80. 发明申请

WO2012136348A1 ADDITIVES TO MITIGATE CATALYST LAYER DEGRADATION IN FUEL CELLS 审中-公开
标题翻译：减轻燃料电池中催化层降解的添加剂
公开(公告)号：WO2012136348A1
公开(公告)日：2012-10-11
申请号：PCT/EP2012/001468
申请日：2012-04-03
申请人： DAIMLER AG , LI, Jing , WANG, Keping , YANG, Yunsong , MCDERMID, Scott , KUNDU, Sumit , FORD MOTOR COMPANY
发明人： LI, Jing , WANG, Keping , YANG, Yunsong , MCDERMID, Scott , KUNDU, Sumit
IPC分类号： H01M8/10
CPC分类号： H01M8/1051 , C08J5/2206 , C08J5/2237 , H01M4/92 , H01M8/1004 , H01M8/1018 , H01M2004/8689
摘要： Ligand additives having two or more coordination sites in close proximity can be used in the polymer electrolyte of membrane electrode assemblies in solid polymer electrolyte fuel cells in order to reduce the dissolution of catalyst, particularly from the cathode, and hence reduce fuel cell degradation over time.
摘要翻译：可以在固体聚合物电解质燃料电池中的膜电极组件的聚合物电解质中使用具有两个或更多个配位点的配位添加剂，以便减少催化剂，特别是阴极的溶解，并因此随着时间的推移而减少燃料电池的降解。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式